ライフサイエンスコーパス: metastatic carcinoma

1 spiration of a right axillary node confirmed metastatic carcinoma.

2 asive adenocarcinoma to castration-resistant metastatic carcinoma.

3 paradigm for clinical intervention of liver metastatic carcinoma.

4 of the three sentinel lymph nodes contained metastatic carcinoma.

5 differentiation from cholangiocarcinoma and metastatic carcinoma.

6 carcinoma, and in metastatic cell lines and metastatic carcinoma.

7 ary for active cell migration in invasive or metastatic carcinoma.

8 Two of the 11 axillary lymph nodes contained metastatic carcinoma.

9 ken for an intraparotid lymph node harboring metastatic carcinoma.

10 erts preneoplastic lesions into invasive and metastatic carcinomas.

11 plasms that progress to locally invasive and metastatic carcinomas.

12 r-reaching implications for the treatment of metastatic carcinomas.

13 or macrophage-activating factors secreted by metastatic carcinomas.

14 adhesion kinase (FAK) are expressed in colon metastatic carcinomas.

15 of non-invasive tumor cells into malignant, metastatic carcinomas.

16 protease associated with rapidly growing and metastatic carcinomas.

17 ents a testable therapeutic approach against metastatic carcinomas.

18 s but delayed their development to invasive, metastatic carcinomas.

19 mas, 18 of 28 primary carcinomas, and 5 of 5 metastatic carcinomas.

20 A1, a human gene with elevated expression in metastatic carcinomas.

21 derstood and unleveraged in the treatment of metastatic carcinomas.

22 n reaction in 30 of 33 EBVaGC cases, 8 of 10 metastatic carcinomas, 14 non-neoplastic tissues from 27

23 ary tumor growth and lung dissemination of a metastatic carcinoma (4T1), but not of a nonmetastatic c

24 nulosa cell (GC) tumors that can progress to metastatic carcinoma and thus provide a model system for

25 on of BKV large T antigen in the primary and metastatic carcinoma, but not in the nonneoplastic uroth

26 concurrently with the transition to invasive metastatic carcinoma, but they were expressed in differe

27 ntous G proteins, which are overexpressed in metastatic carcinomas, but their functions in epithelial

28 silenced alphaB-crystallin in two different metastatic carcinoma cell lines.

29 r actin polymerization in the invadopodia of metastatic carcinoma cells and define four distinct stag

30 Metastatic carcinoma cells exhibit at least two differen

31 In addition, silencing alphaB-crystallin in metastatic carcinoma cells reduced the number of viable

32 The ability of metastatic carcinoma cells to survive matrix detachment

33 ular mechanisms of invadopodium formation in metastatic carcinoma cells.

34 he splenic lesion was performed and revealed metastatic carcinoma, consistent with the lung primary.

35 epithelial neoplasia (HGPIN) to invasive and metastatic carcinoma could facilitate study of the regul

36 slanDCs surround metastatic carcinoma deposits in close proximity to dead

37 hyperplasias, papillomas, and dysplasias to metastatic carcinomas developed in squamous epithelia of

38 distinguish adenocarcinoma of the NPCE from metastatic carcinoma, especially metastatic clear cell r

39 6 per million in Asians) from hemangioma and metastatic carcinoma following the clinical practice.

40 patients in the radical group, only 10% had metastatic carcinoma in the resected retroperitoneal lym

41 ation, lymphoproliferative inflammation, and metastatic carcinomas in the lung after a period of late

42 e been linked to various diseases, including metastatic carcinomas in which the 9 carbon sialic acid

43 ), whereas 10 cholangiocarcinomas and 8 of 9 metastatic carcinomas lacked this staining.

44 were maintained when stratifying tumor into metastatic carcinoma (N = 57) and meningioma (N = 17).

45 Metastatic carcinoma of a renal allograft is a rare but

46 biopsy of the gastric antrum later showed a metastatic carcinoma of breast origin with typical tumor

47 approach to determine tumor type in cases of metastatic carcinoma of clinically unknown origin.

48 18 years) diagnosed with locally advanced or metastatic carcinoma of the pancreas confirmed by cytolo

49 Identifying the primary site in cases of metastatic carcinoma of unknown origin has profound clin

50 lerable, but is unlikely to have activity in metastatic carcinomas of the biliary tree.

51 d 18 years or older initially diagnosed with metastatic carcinoma or who subsequently developed metas

52 Patients with multiple myeloma and metastatic carcinoma to the skeleton who are receiving i

53 Metastatic carcinoma was identified in 10 of 13 axillary

54 clinical diagnosis of verrucous carcinoma or metastatic carcinoma was made.

55 promotes cell migration and is a hallmark of metastatic carcinomas, we asked whether it increases FA

56 biopsies from patients with various advanced metastatic carcinomas, wherein these cells are transitio

57 hat develop extensive HGPIN and invasive and metastatic carcinoma with neuroendocrine (NE) differenti

58 t inhibitor, in 41 patients with progressive metastatic carcinoma with or without mismatch-repair def